IE40523L - Benzylpyrimidine derivatives - Google Patents

Benzylpyrimidine derivatives

Info

Publication number
IE40523L
IE40523L IE741870A IE187074A IE40523L IE 40523 L IE40523 L IE 40523L IE 741870 A IE741870 A IE 741870A IE 187074 A IE187074 A IE 187074A IE 40523 L IE40523 L IE 40523L
Authority
IE
Ireland
Prior art keywords
sulphanilamido
sulphonamides
nhr
sept
pyrimidine
Prior art date
Application number
IE741870A
Other versions
IE40523B1 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to IE1983/77A priority Critical patent/IE40525B1/en
Priority to IE1982/77A priority patent/IE40524B1/en
Publication of IE40523L publication Critical patent/IE40523L/en
Publication of IE40523B1 publication Critical patent/IE40523B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

1484481 Compositions containing benzylpyrimidines F HOFFMANN-LA ROCHE & CO AG 11 Sept 1974 [12 Sept 1973] 39617/74 Heading A5B [Also in Division C2] An antibacterial composition contains a benzylpyrimidine of the formula: wherein R<SP>1</SP> and R<SP>2</SP> are (C 1 -C 3 ) alkyl or alkoxy, or (C 2 or C 3 ) alkenyl or alkenyloxy; Z is NO 2 , NH 2 , pyrrolo, pyrrolidino, piperidino, NHR<SP>4</SP>, -N(R<SP>4</SP>) 2 , -NHR<SP>5</SP>, -NR<SP>4</SP>R<SP>5</SP>, -NR<SP>4</SP>COOR<SP>4</SP>, -NHCOOR<SP>4</SP>, -NHCONHR<SP>3</SP>, -NHCSNHR<SP>3</SP>, -N 3 , -N=N-N(R<SP>4</SP>) 2 or -N(NO)R<SP>4</SP>, R<SP>3</SP> is H, (C 1 -C 3 ) alkyl or (C 2 -C 3 ) alkenyl and R<SP>5</SP> is acyl, and salts thereof; in association with a compatible pharmaceutical carrier. Compounds of the above formula inhibit bacterial dihydrofolate reductase and potentiate the antibacterial activity of sulphonamides with which they may be combined. Specified sulphonamides are sulphisoxazole, sulphadimethoxine, sulphamethoxazole, 4-sulphanilamido-5, 6-dimethoxy-pyrimidine, 2-sulphanilamido-4, 5- dimethyl-pyrimidine, sulphaquinoxaline, sulphadiazine sulphamonomethoxine and 2-sulphanilamido-4, 5-dimethylisoxazole. Other inhibitors for enzymes involved in the folic acid biosynthesis may also be incorporated in the compositions. They may be applied orally, rectally or parenterally. [GB1484481A]
IE1870/74A 1973-09-12 1974-09-09 Novel benzylpyrimidines IE40523B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IE1983/77A IE40525B1 (en) 1973-09-12 1974-09-09 Hydrocinnamic acid nitriles
IE1982/77A IE40524B1 (en) 1973-09-12 1974-09-09 -cyano-hydrocinnamaldehyde acetals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1305773A CH591456A5 (en) 1973-09-12 1973-09-12

Publications (2)

Publication Number Publication Date
IE40523L true IE40523L (en) 1975-03-12
IE40523B1 IE40523B1 (en) 1979-06-20

Family

ID=4388903

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1870/74A IE40523B1 (en) 1973-09-12 1974-09-09 Novel benzylpyrimidines

Country Status (28)

Country Link
JP (1) JPS6042238B2 (en)
AR (2) AR207764A1 (en)
AT (1) AT338797B (en)
BE (1) BE819773A (en)
BR (1) BR7407614D0 (en)
CA (1) CA1037476A (en)
CH (1) CH591456A5 (en)
CU (1) CU34115A (en)
DD (2) DD122785A5 (en)
DE (1) DE2443682C2 (en)
DK (1) DK135683B (en)
ES (7) ES429949A1 (en)
FI (1) FI58638C (en)
FR (1) FR2242984B1 (en)
GB (3) GB1484483A (en)
HK (1) HK181A (en)
HU (1) HU170427B (en)
IE (1) IE40523B1 (en)
IL (1) IL45510A (en)
LU (1) LU70878A1 (en)
NL (1) NL155827B (en)
NO (1) NO140858C (en)
PH (1) PH10643A (en)
PL (2) PL99159B1 (en)
SE (1) SE419443B (en)
SU (3) SU577987A3 (en)
YU (3) YU217874A (en)
ZA (1) ZA745317B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
EP0001633A1 (en) * 1977-10-18 1979-05-02 The Wellcome Foundation Limited Processes for preparing tri-heterocyclic substituted methanes and their conversion into further intermediates useful in the preparation of pharmacologically active compounds
CH639273A5 (en) * 1978-09-12 1983-11-15 Hoffmann La Roche DIURETIC MEANS.
DE3250132C2 (en) * 1981-11-09 1997-01-16 Mallinckrodt Veterinary Inc 2,4-Di:amino-5-benzyl-pyrimidine derivs. prepn.
CH658246A5 (en) * 1981-11-09 1986-10-31 Wellcome Found METHOD FOR PRODUCING SUBSTITUTED 2,4-DIAMINO-5-BENZYLPYRIMIDINES.
GB2180836A (en) * 1985-09-27 1987-04-08 William James Stephen Barker Sunscreen
JPH0431685Y2 (en) * 1987-06-01 1992-07-30
CA1300166C (en) * 1987-12-03 1992-05-05 Alfredo Guerrato Process for the preparation of a benzoic acid ester
US4900859A (en) * 1987-12-03 1990-02-13 Hoffman-La Roche Inc. Process for 4-dimethylamino-3,5-dimethoxybenzaldehyde

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1103931B (en) * 1957-02-21 1961-04-06 Wellcome Found Process for the preparation of 2,4-diamino-5-benzylpyrimidine derivatives
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes

Also Published As

Publication number Publication date
ES437012A1 (en) 1977-04-01
AU7263174A (en) 1976-02-26
AR207764A1 (en) 1976-10-29
CH591456A5 (en) 1977-09-15
JPS5053385A (en) 1975-05-12
ES429949A1 (en) 1976-10-01
AT338797B (en) 1977-09-12
IL45510A (en) 1978-08-31
SU571189A3 (en) 1977-08-30
DD122785A5 (en) 1976-11-05
DK135683B (en) 1977-06-06
ES437008A1 (en) 1977-04-01
SE419443B (en) 1981-08-03
ES437007A1 (en) 1977-04-01
GB1484481A (en) 1977-09-01
DE2443682A1 (en) 1975-03-20
FR2242984B1 (en) 1977-11-04
PH10643A (en) 1977-07-22
CA1037476A (en) 1978-08-29
FI58638B (en) 1980-11-28
BE819773A (en) 1975-03-11
YU301580A (en) 1983-04-27
BR7407614D0 (en) 1975-07-08
SU577987A3 (en) 1977-10-25
YU301680A (en) 1983-04-27
FI256174A (en) 1975-03-13
AR211387Q (en) 1977-12-15
DK468374A (en) 1975-05-12
NO140858C (en) 1979-11-28
ES437013A1 (en) 1977-04-01
ZA745317B (en) 1975-11-26
JPS6042238B2 (en) 1985-09-20
CU21022L (en) 1981-09-09
FR2242984A1 (en) 1975-04-04
IL45510A0 (en) 1974-11-29
PL99159B1 (en) 1978-06-30
NO743271L (en) 1975-04-07
NL7411685A (en) 1975-03-14
HK181A (en) 1981-01-16
CU34115A (en) 1983-10-04
DE2443682C2 (en) 1983-11-10
LU70878A1 (en) 1976-08-19
SU609465A3 (en) 1978-05-30
SE7411382L (en) 1975-03-13
DK135683C (en) 1977-11-14
DD116824A5 (en) 1975-12-12
ATA735174A (en) 1977-01-15
HU170427B (en) 1977-06-28
IE40523B1 (en) 1979-06-20
NL155827B (en) 1978-02-15
YU37153B (en) 1984-08-31
FI58638C (en) 1981-03-10
GB1484482A (en) 1977-09-01
PL97757B1 (en) 1978-03-30
GB1484483A (en) 1977-09-01
NO140858B (en) 1979-08-20
YU217874A (en) 1982-06-18
YU37154B (en) 1984-08-31
ES437009A1 (en) 1977-04-01
ES437011A1 (en) 1977-04-01

Similar Documents

Publication Publication Date Title
HK1020672A1 (en) Pharmaceutical compositions containing sulphamate derivatives as steroid sulphatase inhibitors
AU4798000A (en) Triarylimidazoles
IE862297L (en) Sulfamic acid derivatives.
IE810906L (en) ß-LACTAM COMPOUNDS
IL148426A0 (en) α-HYDROXY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IE40523L (en) Benzylpyrimidine derivatives
AU2736088A (en) Pharmaceutical compositions comprising benzylidene- and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation
ES8207169A1 (en) 4-Amino-6,7-dimethoxy-2-piperazinylquinazoline derivatives, their preparation and use
GB1402498A (en) Triazine derivatives their production and their medicinal use
MY128323A (en) Thiazole derivatives for inhibition of cytokine production and of cell adhesion
GR1002573B (en) Microbial process for preparing mevinolin.
ES8700261A1 (en) Carbapenems having a 2-quaternary pyridine altylthio or pyridine alkenylthio substituent, compositions containing the same and combinations with DHP inhibitors.
CA2265666A1 (en) Cytostatic hydroxamic acid derivatives
IE890748L (en) Peptides with pharmaceutical activity
AU7592796A (en) Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
IE36867L (en) Potentiated antimicrobial compositions
EP0664127A3 (en) Pharmaceutical compositions containing isoquinoline derivatives
EP1319658A4 (en) Imidazole derivatives or their salts
EP1136488A4 (en) Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
GB1369294A (en) Purine-ribofuranoside-2,5,-cyclophosphates
AU4620796A (en) Thiol derivatives with metallopeptidase inhibitory activity
IE45399L (en) 7-arylmalonamidomethoxycephalosporins.
IE890747L (en) Peptides with pharmaceutical activity
CA2245484A1 (en) Novel urea derivatives
IE791164L (en) L-cysteine derivatives.